Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox.


BACKGROUND AND AIM Development of effective antifibrotic treatments that can be translated to clinical practice is an important challenge in contemporary hepatology. A recent report on β-thalassemia patients demonstrated that deferasirox treatment reversed or stabilized liver fibrosis independent of its iron-chelating properties. In this study, we… (More)
DOI: 10.1111/jgh.12720


6 Figures and Tables